INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 64 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $12,000 | -29.4% | 22,900 | 0.0% | 0.00% | – |
| Q4 2017 | $17,000 | -50.0% | 22,900 | 0.0% | 0.00% | – |
| Q3 2017 | $34,000 | -96.7% | 22,900 | -94.1% | 0.00% | – |
| Q2 2017 | $1,043,000 | -44.5% | 384,976 | -17.0% | 0.00% | – |
| Q1 2017 | $1,878,000 | +2.3% | 463,666 | +6.5% | 0.00% | – |
| Q4 2016 | $1,835,000 | -35.6% | 435,559 | +4.0% | 0.00% | – |
| Q3 2016 | $2,848,000 | +20.0% | 418,751 | +2.0% | 0.00% | – |
| Q2 2016 | $2,373,000 | -15.0% | 410,504 | +2.5% | 0.00% | – |
| Q1 2016 | $2,793,000 | +13.8% | 400,297 | +17.5% | 0.00% | – |
| Q4 2015 | $2,455,000 | -13.6% | 340,562 | +3.2% | 0.00% | – |
| Q3 2015 | $2,842,000 | -35.1% | 329,878 | +21.8% | 0.00% | – |
| Q2 2015 | $4,378,000 | – | 270,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMS Capital Management | 435,988 | $1,766,000 | 1.77% |
| WELCH & FORBES LLC | 508,649 | $2,060,000 | 0.06% |
| Hayek Kallen Investment Management | 12,015 | $49,000 | 0.03% |
| Indiana Trust & Investment Management CO | 13,250 | $54,000 | 0.03% |
| FLAGSHIP HARBOR ADVISORS, LLC | 16,007 | $62,000 | 0.02% |
| BOSTON FINANCIAL MANGEMENT LLC | 61,675 | $250,000 | 0.02% |
| HYMAN CHARLES D | 30,000 | $121,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $1,620,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 90,650 | $367,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 243,781 | $987,000 | 0.00% |